After watching Dr Shah's presentation on the Azer-cel (PBCAR0191) trial update, particularly the neurotoxicity & infection episodes they are seeing, I'm suprised that IMU have not seen fit to release an update to the market.
Dr Shah, an IMU investigator, is sharing what looks to be very price senstive news with medical colleagues and these results on neurotoxicity & infections
would be of interest (concern ?) to most shareholders. If they knew....
https://www.vjhemonc.com/event/iwcar-t-2024/
And ditto for the changes to the trial time-lines recently updated on clinicaltrials.gov
https://clinicaltrials.gov/study/NCT03666000?intr=PBCAR0191&rank=1
IMU management aren't doing SH'rs any favours by keeping them in the dark, and are potentially in breach of ASX continuous disclosure rules imo ... !
After watching Dr Shah's presentation on the Azer-cel...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 4542680 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 1675759 | 9 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |